The tripartite-motif (TRIM) family of proteins represents one of the largest classes of putative single protein RING-finger E3 ubiquitin ligases. The members of this family are characterized by an N-terminal TRIM motif containing one RING-finger domain, one or two zinc-finger domains called B boxes (B1 box and B2 box), and a coiled-coil region.
and B2 box), and its associated coiled-coil region. 2 The main structural differences within the family of TRIM proteins are determined by diverse C-terminal domains. Based on the C-terminus, TRIM proteins are classified into 11 groups (from C-I to C-XI). Some of the TRIM proteins do not possess a RING-finger domain within the TRIM motif and constitute the 12th group of unclassified (UC) TRIM proteins. 3 Mammalian TRIM gene expression is generally constitutive and ubiquitous during embryonic development and in adult tissues (with some exceptions). 4 Within the same cell, several different TRIM transcripts (originating from alternative splicing events) may emerge, leading to diverse predicted protein products. These TRIM isoforms can possess different biochemical properties and play various roles in cell biology. 5, 6 To date, TRIM proteins were demonstrated to regulate cell proliferation, 7, 8 cell division, and developmental processes 9, 10 ; facilitate or suppress cell transformation to cancer 11 ; control cell metabolism 12 ; regulate autophagocytosis 13 ; mediate chromatin modifications 8 ; positively or negatively regulate gene transcription [14] [15] [16] ; add post-translational modifications to target proteins 2, 17 ; directly interact with pathogens having a predominant role in innate immunity 2 ; and many others. In this review, the relationship between TRIM family members and cell stemness was highlighted (with tumorigenesis as a background).
| MECHANISMS PROVIDING STEM CELL SELF-RENEWAL
The last two decades of research have harnessed enormous forces to define and deeply characterize the specific population of cancer cells termed cancer stem cells (CSCs). Originally, CSCs were defined as a population with the capability to self-renew and differentiate, and they are highly responsible for tumor growth and progression. 18, 19 CSCs are endowed with intrinsic resistance to chemo-and radiotherapy, possessing a high metastatic potential, and providing tumor relapse after treatment. Usually considered to be a small population of cells, CSCs appeared to be heterogeneous and sometimes numerous within specific types of cancer. Functional and phenotypical properties of these cells are substantially influenced by genetic, epigenetic, and microenvironmental factors. 18, 20, 21 Because of their high plasticity, CSCs may experience phases of transition between stem-like and non-stem-like states. 18, 20, 21 Therefore, the concept of CSCs has to be redefined. A growing body of evidence demonstrates that bulk tumor cells can acquire stem cell properties in response to exogenous stimuli. This suggests that the process of cancer cell differentiation can be reversed and further adds to the complexity of cancer stemness. 19, 20 In this review, we have considered the stemness of cancer cells as a specific state a cancer cell can achieve and maintain and characterized the mechanisms that regulate this phenomenon. Among others, the activation of specific signaling pathways and the induction of several transcription factors play a fundamental role 18, 22 in the regulation of stem cell pluripotency.
Signaling pathways that provide stem cell self-renewal are frequently harnessed by cancer cells, leading to increased aggressiveness and the acquisition of the stem cell phenotype. 22 Specifically, the JAK/STAT, Hedgehog, Wnt/β-catenin, Notch, PI3K/Akt, TGF-β, and NF-κB signaling pathways have all been shown to mediate various stem cell properties. The over-activation or abnormal signaling within these pathways contributes to the survival of CSCs. 18, 22 Many of these pathways are not linear, but rather interwoven networks of signaling mediators that feed into one another, facilitating inter-pathway cross talk. Furthermore, both extrinsic and intrinsic molecular signals, as well as several regulatory elements, escalate the complexity of these pathways, making it difficult to identify the central stemness determinant.
The activation of pluripotency-facilitating signaling pathways leads ultimately to the induction of stem cell-specific core transcription factor machinery, including Oct-3/4, Sox2, and Nanog transcription factors. 23 These factors regulate the expression of two distinct groups of genes: those engaged in self-renewal (activated) and those involved in cell differentiation (silenced). Additionally, numerous studies have demonstrated their role in tumorigenesis and revealed a significant correlation with worse patient outcome, tumor dedifferentiation status, and stemness acquisition. 21 Besides core pluripotency transcription factor machinery, there are other mediators that regulate the expression of pluripotency or differentiating genes. These include non-coding RNAs (such as miRNAs) and chromatin regulators, which stabilize stem cell expression patterns through post-transcriptional modulations and epigenetic mechanisms (including DNA methylation and histone modifications), respectively. 24 The role of epigenetic mechanisms in defining tumor heterogeneity and acquisition or maintenance of the CSC phenotype is now being extensively studied. 25, 26 Previous studies demonstrated that normal stem cell and cancer cell metabolism are overtly similar, using mainly glycolysis. However, a closer look at the metabolic requirements of the CSC population revealed a distinct metabolic phenotype for normal stem cells and for bulk tumor cells. 27, 28 Studies have shown that mitochondrial function is crucial for the maintenance of the stem cell phenotype. 29 Additionally, the "metabolic switch" from glycolysis to OXPHOS (oxidative phosphorylation) is believed to play a critical role in the stemness acquisition rather than being the consequence of metabolic reprogramming to pluripotency. 27, 28 Recent studies have also highlighted the indisputable role of epithelial-to-mesenchymal transition (EMT) in the acquisition and
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Tripartite-motif (TRIM) proteins are involved in a variety of cellular functions and biological processes, and recent data revealed their significant role in the acquisition and maintenance of the stem cell phenotype. The present article describes those TRIM family members that facilitate cell stemness and discusses others for which further studies are needed to understand their full contribution to stem cell self-renewal. maintenance of stem cell-like properties. As demonstrated previously, EMT is sufficient to endow cancer cells with stem cell characteristics, facilitating cancer resistance to therapeutic agents and resulting in cancer recurrence and progression. 30, 31 In summary, numerous mechanisms enable cancer cells to acquire and maintain the stem cell phenotype. Most of them are interrelated and influence each other, considerably increasing the complexity of CSC regulation. An ever-growing number of studies demonstrate significant engagement of distinct TRIM family members in each of the abovementioned biological processes.
| THE ENGAGEMENT OF SPECIFIC TRIMS IN STEM CELL MAINTENANCE
Because of the large number of TRIM family members and the complex nature of the mechanisms governing stem cell maintenance, in this review, we focused on TRIM proteins, which play a role in the machinery that provides stem cell self-renewal and that was directly confirmed experimentally. However, the involvement of the remaining TRIM family members in the cell stemness acquisition or maintenance should not be excluded or negated because of the high relativity of TRIMs to each other.
Among the members of classes IV to VII and among the 12th group of UC TRIMs, there are proteins that were previously reported to provide or to suppress the stem-like phenotype acquisition or maintenance ( Table 1) 
| TRIM family members with C-terminal PHD and BROMO domains (class VI)
The sixth class of TRIM family proteins consists of three proteins: Therefore, TRIM24 is essential to mediate EGFR-driven glioma stem cell proliferation and self-renewal. 7 Additionally, TRIM24, as a ubiquitin E3 ligase, keeps the p53 protein at a low level in normal pluripotent stem cells, which facilitates their self-renewal. 43 TRIM28 uses KRAB-ZNFs to cause epigenetic silencing of its target differentiation genes via H3K9me3 and DNA methylation, sustaining the self-renewal of human pluripotent stem cells. 15, 16 Additionally, TRIM28 is essential to maintain stem cell properties of cancer cells. Together with MAGE-A3/6, TRIM28 forms a cancer-specific ubiquitinase that regulates the AMPK level in cancer cells, enhancing oxidative phosphorylation and maintaining stem cell traits. 52 Moreover, TRIM28 regulates specific mediators of EMT at both transcriptional and posttranscriptional levels and it was previously reported to directly induce EMT program, 53 which may further result in the acquisition of stem cell-like phenotype.
TRIM33 (TIF1γ) is known to be a transcriptional co-repressor. 58 In contrast to TRIM24 and TRIM28, TRIM33 seems to be a positive regulator of stem cell differentiation (TRIM33 loss does not affect stem cell self-renewal, but it impairs differentiation process) and a growing amount of data suggests that TRIM33 directly mediates TGF-β signaling and plays a role in Wnt/β-catenin signaling to provide proper differentiation during early mouse embryonic development. 59 
| TRIM family members with C-terminal NHL and FIL domains (class VII)
TRIM32 is a member of class VII with C-terminal NHL domain. The molecular role of TRIM32 in stem cell fate specification is based on two mechanisms: the induction of specific microRNAs activity (through NHL-mediated association with Argonaute 1 protein) 54 and RINGmediated ubiquitination and proteasomal degradation of c-Myc. 54, 55, 60 Another class VII member, TRIM71, has a C-terminal NHL domain preceded by Filamin domain, and was reported to positively regulate stem cell self-renewal. TRIM71, also known as LIN41, facilitates the G1-S transition (through CDKN1A repression) to promote rapid embryonic stem cell self-renewal. 56 TRIM71 associates with and catalytically activates Argonaute 2 through the NHL domain. This interaction potentiates specific microRNA functions and consequently leads to suppression of CDKN1A expression. Additionally, TRIM71 promotes reprogramming of somatic cells to induce pluripotent stem cells by suppression of a broad array of differentiation genes (as a consequence of direct inhibition of EGR1 mRNA translation). 61 Altogether, TRIM71
is critical for the regulation of stem cell self-renewal.
| Other TRIM family members potentially involved in the regulation of stem cell properties
For several TRIMs, the exact mechanism of stem cell regulation remains unknown, although their engagement seems essential. Low In cancer cells, the regulation of stem cell-associated signaling pathways by TRIM proteins occurs either via the ubiquitination and proteasomal degradation of specific pathway components 33, 57, 59 or by direct binding and stabilization of downstream mediators 34, 35 (further recruited to chromatin to regulate target gene expression). However, for several TRIMs, the molecular mode of action is yet not fully understood and the data suggest the participation of additional factors. 36, 38, 39, 48 Similarly, TRIM-mediated regulation of core pluripotency transcription factor machinery is based on the E3 ubiquitin ligase activity (mediated by the RING domain) 32, 55, 60 or the ability to form a complex and stabilize specific transcription factors 14, 50, 51 (unfortunately, it has not been precisely defined whether the TRIM motif is always required for protein-protein interactions).
Several TRIMs also play the role of transcription cofactors that are involved activating the expression of other pluripotency genes or in suppressing differentiating markers. All members of the sixth class of TRIM proteins (TRIM24, TRIM28, and TRIM33) that possess C-terminal PHD and BROMO domains are engaged in the stemness regulation at this level (either as activators of pluripotency genes or suppressors of differentiating markers). Besides using the TRIM motif, these proteins engage both PHD and BROMO domains to exert their specific functions. 15, 16, 45, 58 Distinct TRIM members were also shown to participate in epigenetic mechanisms underlying the acquisition or maintenance of CSC phenotype. Among the factors that recruit chromatin-remodeling complexes, we can find both mediators of chromatin condensation (TRIM28) and open chromatin maintainers (TRIM19). In both cases, the TRIM motif plays an essential role in forming a supramolecular assembly. 8, 15, 41, 68 The E3 ubiquitin ligase activity mediated by the RING domain is commonly used by specific TRIM proteins to exert the stem cell-associated function. Besides the abovementioned targets for ubiquitination and proteasomal degradation, the level of several other proteins is tightly regulated by TRIM members to maintain the pluripotent state (ie, components of the cell cycle regulatory circuit [p53] or proteins associated with cell metabolism [AMPK]). 8, 43, 52 Therefore, the presence of a catalytically active RING domain that could be blocked by chemical compounds might make TRIM family members attractive targets for the manipulation of stem cell homeostasis.
| CONCLUSION
The role of TRIM family members in cancer development and progression has been studied for years, determining both oncogenic and tumor suppressive members. A growing number of TRIM proteins are engaged in regulating the CSC population, which is mostly responsible for tumor growth and progression, metastases, and resistance to anticancer therapies. Acquisition of stem cell properties and the ability to sustain a stem-like phenotype by cancer cells is guaranteed by several TRIM members, but via the use of distinct mechanisms. For other members, further work using biochemical approaches as well as genetic knock-in and knockout experiments in mice is needed to understand the full contribution of these TRIMs to stem cell self-renewal. Additionally, it is important to identify the TRIMs that potentially serve as therapeutic targets. Targeting those TRIMs might result in disruption of the machinery of stemness acquisition and consequently, might prevent tumor relapse.
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